Devanjali Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 14-12-2024
- Paid Up Capital ₹ 0.10 M
as on 14-12-2024
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 45.68%
(FY 2022)
- Profit 145.01%
(FY 2022)
- Ebitda 147.59%
(FY 2022)
- Net Worth 8.56%
(FY 2022)
- Total Assets 11.30%
(FY 2022)
About Devanjali Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jitendrakumar Panchamiya, Samir Gohel, Dharmishthaben Suchak, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999GJ2016PTC092568
- Company No.
092568
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jun 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Devanjali Pharma Private Limited offer?
Devanjali Pharma Private Limited offers a wide range of products and services, including Ayurvedic Herbal Syrups & Tonics, Herbal Cough Syrup, Herbs,Sticks and Roots, Ayurvedic Indian Herbs, Hair Shampoo, Herbal Shampoo, Common Disease Medicines, Pharmaceutical Capsules, Anti-Itch Skin Cream, Diabetic Herbal Medicine.
Who are the key members and board of directors at Devanjali Pharma?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jitendrakumar Panchamiya  | Director | 21-Jun-2016 | Current |
| Samir Gohel | Director | 21-Jun-2016 | Current |
| Dharmishthaben Suchak | Director | 21-Jun-2016 | Current |
| Parul Unadkat | Director | 21-Jun-2016 | Current |
| Deepaben Butani | Director | 21-Jun-2016 | Current |
Financial Performance of Devanjali Pharma.
Devanjali Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 45.68% increase. The company also saw a substantial improvement in profitability, with a 145.01% increase in profit. The company's net worth moved up by a moderate rise of 8.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Devanjali Pharma?
Unlock access to Devanjali Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Rapier Pharmaceutical Private LimitedActive 13 years 7 monthsJitendrakumar Panchamiya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Devanjali Pharma?
Unlock and access historical data on people associated with Devanjali Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Devanjali Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Devanjali Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
